Andrea V. Scalise

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis.

Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis.

Journal: European heart journal

Published: July 24, 2026

Hypokalemia and New-Onset Diabetes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.

Hypokalemia and New-Onset Diabetes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.

Journal: Diabetes care

Published: June 03, 2026

The HFpEF-ABA Score, Incident Heart Failure, and Finerenone in Chronic Kidney Disease with Type 2 Diabetes.

The HFpEF-ABA Score, Incident Heart Failure, and Finerenone in Chronic Kidney Disease with Type 2 Diabetes.

Journal: Journal of cardiac failure

Published: May 21, 2026

Characterizing children with chronic kidney disease and severe proteinuria in the United States: a retrospective analysis using electronic health records.

Characterizing children with chronic kidney disease and severe proteinuria in the United States: a retrospective analysis using electronic health records.

Journal: Pediatric nephrology (Berlin, Germany)

Published: March 24, 2026

Correction: Investigating the use of finerenone in children with chronic kidney disease and proteinuria: design of the FIONA and open-label extension studies.

Correction: Investigating the use of finerenone in children with chronic kidney disease and proteinuria: design of the FIONA and open-label extension studies.

Journal: Trials

Published: February 04, 2026

Effects of Finerenone Across a Range of Heart Failure Duration: A Prespecified Analysis of the FINEARTS-HF Trial.

Effects of Finerenone Across a Range of Heart Failure Duration: A Prespecified Analysis of the FINEARTS-HF Trial.

Journal: European journal of heart failure

Published: October 23, 2025

Finerenone in patients with severe heart failure: The FINEARTS-HF trial.

Finerenone in patients with severe heart failure: The FINEARTS-HF trial.

Journal: European journal of heart failure

Published: August 25, 2025

Efficacy and Tolerability of Finerenone According to the Use and Dosage of Diuretics: A Prespecified Analysis of the FINEARTS-HF Randomized Clinical Trial.

Efficacy and Tolerability of Finerenone According to the Use and Dosage of Diuretics: A Prespecified Analysis of the FINEARTS-HF Randomized Clinical Trial.

Journal: JAMA cardiology

Published: August 13, 2025

Efficacy of finerenone in patients with heart failure and mildly reduced or preserved ejection fraction: a prespecified analysis of heart rate and heart rhythm in the FINEARTS-HF trial.

Efficacy of finerenone in patients with heart failure and mildly reduced or preserved ejection fraction: a prespecified analysis of heart rate and heart rhythm in the FINEARTS-HF trial.

Journal: European journal of heart failure

Published: August 07, 2025

Sex differences in cardiovascular-kidney-metabolic syndrome: the FINE-HEART pooled analysis.

Sex differences in cardiovascular-kidney-metabolic syndrome: the FINE-HEART pooled analysis.

Journal: European heart journal

Published: August 04, 2025

Finerenone According to Frailty in Heart Failure: A Prespecified Analysis of the FINEARTS-HF Randomized Clinical Trial.

Finerenone According to Frailty in Heart Failure: A Prespecified Analysis of the FINEARTS-HF Randomized Clinical Trial.

Journal: JAMA cardiology

Published: June 18, 2025

Effects of Finerenone on Readmissions for Heart Failure: Insights From the FINEARTS-HF Trial.

Effects of Finerenone on Readmissions for Heart Failure: Insights From the FINEARTS-HF Trial.

Journal: Journal of cardiac failure

Published: May 12, 2025

Showing 1-12 of 27

Last Updated: 09/26/2026